Healthcare / Medical DistributionThailand
$1.56
-0.06 (-3.70%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 32% · confianza 23%
FCF escenarios
weak_data · normalized FCF $35.6M · quality 47.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
45/100
C
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$265M
P/E
8.2x
↓EV/EBITDA
2.5x
↓ROE
14.9%
↑Gross Margin
34.8%
↓Debt/Equity
0.32
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+11.9%
FCF CAGR
+2.5%
FCF margin
7.9%
FCF / Net income
0.76x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $449.7M · net income $46.5M · FCF $35.6M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $449.7M | $449.7M | $444.0M | $393.6M | $320.5M |
| Net Income | $46.5M | $46.5M | $52.2M | $21.9M | $17.9M |
| EBITDA | $75.6M | $75.6M | $82.0M | $45.6M | $42.2M |
| EPS | 0.27 | 0.27 | 0.39 | 0.13 | 0.11 |
| Gross Margin | 34.8% | 34.8% | 34.8% | 29.6% | 31.6% |
| Operating Margin | 12.8% | 12.8% | 14.7% | 7.6% | 7.3% |
| Net Margin | 10.3% | 10.3% | 11.8% | 5.6% | 5.6% |
| Balance Sheet | |||||
| Debt/Equity | 0.32 | 0.32 | 0.34 | 1.55 | 3.21 |
| Current Ratio | 2.23 | 2.23 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $35.6M | $35.6M | $39.6M | $-30.3M | $33.1M |
| Returns | |||||
| ROE | 14.9% | 14.9% | 18.5% | 27.6% | 63.0% |
| Valuation | |||||
| P/E | 8.21 | 8.21 | 10.51 | — | — |
| EV/EBITDA | 2.51 | 2.51 | 5.77 | — | — |
| P/B | 0.85 | 0.85 | 1.95 | — | — |
| Growth & Yield | |||||
| Revenue Growth | 1.3% | 1.3% | 12.8% | 22.8% | — |
| EPS Growth | -30.8% | -30.8% | 203.1% | 22.4% | — |
| Dividend Yield | 7.0% | 7.0% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-20.0%
EPS terminal req.
$0.14
Spread vs growth
-10.8%
5Y implied EPS CAGR
-9.1%
EPS terminal req.
$0.17
Spread vs growth
-21.7%
10Y implied EPS CAGR
-0.0%
EPS terminal req.
$0.27
Spread vs growth
-30.8%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-44.2%
Start / end P/E
8.2x → 5.8x
EPS bridge
0.39 → 0.27
Residual
+9.1%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.